EZH2 inhibitor (DZNep) was found to inhibit multiple histone methylation and was sufficient to suppress liver fibrosis by modulating histone methylation of HSC in a mouse model (Zeybel et al., 2017). This evidence concerns the gene EZH2 and Hepatic fibrosis.